Recent Developments in Phenotypic and Molecular Diagnostic Methods for Antimicrobial Resistance Detection in Staphylococcus aureus: A Narrative Review - PubMed (original) (raw)

Review

Recent Developments in Phenotypic and Molecular Diagnostic Methods for Antimicrobial Resistance Detection in Staphylococcus aureus: A Narrative Review

Andrea Sanchini. Diagnostics (Basel). 2022.

Abstract

Staphylococcus aureus is an opportunistic pathogen responsible for a wide range of infections in humans, such as skin and soft tissue infections, pneumonia, food poisoning or sepsis. Historically, S. aureus was able to rapidly adapt to anti-staphylococcal antibiotics and become resistant to several classes of antibiotics. Today, methicillin-resistant S. aureus (MRSA) is a multidrug-resistant pathogen and is one of the most common bacteria responsible for hospital-acquired infections and outbreaks, in community settings as well. The rapid and accurate diagnosis of antimicrobial resistance in S. aureus is crucial to the early initiation of directed antibiotic therapy and to improve clinical outcomes for patients. In this narrative review, I provide an overview of recent phenotypic and molecular diagnostic methods for antimicrobial resistance detection in S. aureus, with a particular focus on MRSA detection. I consider methods for resistance detection in both clinical samples and isolated S. aureus cultures, along with a brief discussion of the advantages and the challenges of implementing such methods in routine diagnostics.

Keywords: MRSA; Staphylococcus aureus; antibiotic resistance; antimicrobial stewardship; antimicrobial susceptibility testing; molecular methods; phenotypic methods; point of care; rapid detection; resistance detection.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1

Figure 1

Overview of the search strategy and the study selection procedure used in this narrative review.

Similar articles

Cited by

References

    1. Murray P., Rosenthal K., Pfaller M.A. Medical Microbiology. 9th ed. Elsevier; Amsterdam, The Netherlands: 2020.
    1. Center for Disease Control and Prevention Healthcare Settings Preventing the Spread of MRSA. [(accessed on 30 November 2021)]; Available online: https://www.cdc.gov/mrsa/healthcare/index.html.
    1. Rammelkamp C.H., Maxon T. Resistance of Staphylococcus aureus to the Action of Penicillin. Proc. Soc. Exp. Biol. Med. 1942;51:386–389. doi: 10.3181/00379727-51-13986. - DOI
    1. Jevons M.P. “Celbenin”-resistant Staphylococci. Br. Med. J. 1961;1:124. doi: 10.1136/bmj.1.5219.124-a. - DOI
    1. Uhlemann A.C., Otto M., Lowy F.D., DeLeo F.R. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect. Genet. Evol. 2014;21:563–574. doi: 10.1016/j.meegid.2013.04.030. - DOI - PMC - PubMed

Publication types

LinkOut - more resources